NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹11 Cr | ₹39 Cr | ₹34 Cr | ₹-25 Cr | ₹-0.81 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATH BIOGENES (INDIA) ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹39 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹-25 Cr |
| Mar2013 | ₹-0.81 Cr |
How is Net Cash Inflow / Outflow of NATH BIOGENES (INDIA) Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | -70.85 | |
| Mar2024 | ₹39 Cr | 16.56 | |
| Mar2023 | ₹34 Cr | Positive | |
| Mar2022 | ₹-25 Cr | Negative | |
| Mar2013 | ₹-0.81 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹266.1 Cr | -0.6% | -6.5% | -5.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,484.3 Cr | 0.4% | -17.4% | -7.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,185.9 Cr | 0.2% | -3.8% | -31.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,837.2 Cr | 7% | -8.4% | -19.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹823.0 Cr | -3.9% | -15.5% | -36.1% | Stock Analytics | |
| INDO US BIOTECH | ₹210.9 Cr | 5.2% | -30% | -38.5% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -0.6% |
-6.5% |
-5.3% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses